HOWL
Werewolf Therapeutics Inc
Price:  
1.85 
USD
Volume:  
320,111.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HOWL WACC - Weighted Average Cost of Capital

The WACC of Werewolf Therapeutics Inc (HOWL) is 7.5%.

The Cost of Equity of Werewolf Therapeutics Inc (HOWL) is 8.70%.
The Cost of Debt of Werewolf Therapeutics Inc (HOWL) is 7.00%.

Range Selected
Cost of equity 7.40% - 10.00% 8.70%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.6% - 8.4% 7.5%
WACC

HOWL WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.76 0.92
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.40% 10.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.49 0.49
Cost of debt 7.00% 7.00%
After-tax WACC 6.6% 8.4%
Selected WACC 7.5%